Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2023 was expected before 31 July 2024 and has not been filed.
-
Busy address KBO
78 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2022
VUKANEOS PHARMA from Mont-Saint-Guibert, company number BE0839519855, closed financial year 2022 with a result of € 11,722 after tax. For that financial year VUKANEOS PHARMA recorded a gross margin of € 17,774 and equity of € 22,728. Compared with financial year 2021, the result moved from € 7,530 to € 11,722. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2023.
€ 22,728
▲ 107% vs 2021
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 11,722
▲ 56% vs 2021
Profit after tax over the fiscal year.
€ 4
▼ € 794 vs 2021
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2022. Retained profit grew to € 4,128.
People and assets in 2022
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2022
None
No bank loans on the last day of the fiscal year.
€ 5,557
▲ 151% vs 2021
Supplier invoices still open on the last day of the fiscal year.
€ 24,456
▲ 22% vs 2021
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | Change 2021 → 2022 | |
|---|---|---|---|
| Gross margin | € 13,467 | € 17,774 | ▲ 32% |
| Profit after taxes | € 7,530 | € 11,722 | ▲ 56% |
| Equity | € 11,006 | € 22,728 | ▲ 107% |
| Total debts | € 22,241 | € 30,014 | ▲ 35% |
| Cash | € 798 | € 4 | ▼ € 794 |
| Retained profit | € -7,594 | € 4,128 | ▲ € 11,722 |
| Balance sheet total | € 33,247 | € 52,741 | ▲ 59% |
Key figures of VUKANEOS PHARMA, fiscal years 2021 to 2022, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2023 has not been filed yet; it was expected before 31 July 2024.
What happened to VUKANEOS PHARMA?
What happened at VUKANEOS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2022: profit of € 11,722 (▲ 56% vs 2021). Source: NBB ↗
- New establishment in Mont-Saint-Guibert. KBO
- Start of the company according to the CBE. KBO
In short
From € 7,530 profit in 2021 to € 11,722 profit in 2022.
Paid € 8,812 in corporate taxes since 2021.
Best year ever: 2022, with € 11,722 profit.
A new publication or filing at VUKANEOS PHARMA? We notify you, reason included.
Follow VUKANEOS PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind VUKANEOS PHARMA is Nicodème Ntamahungiro.
Directors
According to the 2022 annual accounts
Nicodème Ntamahungiro
Director
Establishments
Establishment units
Physical locations of this company
Rue du Fond Cattelain 2 box 2.2
1435 Mont-Saint-Guibert
Rue du Fond Cattelain 2 box B2.2
1435 Mont-Saint-Guibert
Active since 22 September 2011
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 78 companies are registered at this address.
All companies at this address →INNOVATIE CONSTRUCTION COMPANY
€ 5,187 gross margin · 2024
Novoffice Global IT
€ -1,994 gross margin · 2025
Diffusion Brabant
TACT
€ 1,041 gross margin · 2024
TRADEWARE
€ 751,690 revenue · 2025
+73 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0839.519.855
- VAT number
- BE 0839.519.855
- Registered office
- Rue du Fond Cattelain 2 bus 2.2, 1435 Mont-Saint-Guibert
- Names & denominations
- VUKANEOS PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 September 2011
- Peppol
- Active · Active since 28 Aug 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Adviesbureaus op het gebied van public relations en communicatie